Skip to main content

Safety and Pharmacokinetic

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Medibiofarma
MedibiofarmaSpain - Navarrra
1 program
1
MBF-015 4 mg oral capsulePhase 11 trial
Active Trials
NCT06049147Completed72Est. Aug 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MedibiofarmaMBF-015 4 mg oral capsule

Clinical Trials (1)

Total enrollment: 72 patients across 1 trials

NCT06049147MedibiofarmaMBF-015 4 mg oral capsule

Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers

Start: Jul 2021Est. completion: Aug 202372 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.